| Literature DB >> 30587803 |
Cyntia S Freitas1, Genilton Alves da Silva2, Daniel Perrone3, Mauricio A Vericimo4, Diego Dos S Baião5, Patrícia R Pereira6, Vânia M F Paschoalin7, Eduardo M Del Aguila8.
Abstract
Soybeans display strategic potential in food security as a source of protein and functional bioactives for human consumption. Polyphenols and other bioactive compounds can be recovered after an aqueous extraction from soybean meal, a byproduct of soy oil refining. The objective of the present study was to compile and quantify compounds from soybean oil refinery by-products, providing information about valuable bioactive phytochemicals, their bioaccessibility and potential bioactivities. Genistin, daidzin, glycitin and malonylgenistin were the predominant isoflavones, and the overall bioaccessibility of their glycosidic forms was of nearly 75%. Sixteen phenolics were identified and caffeic acid, 5-caffeoylquinic chlorogenic acid and hesperidin were the most predominant. Approximately 30% of gallic acid, syringic acid, vanillic acid and myricetin were released and the antioxidant capacity of aqueous extract was enhanced after simulated in vitro gastro intestinal digestion. The ability of aqueous soybean meal extract to inhibit lipid peroxidation was higher than natural and synthetic food antioxidants. Antimicrobial activity against several foodborne pathogens and antitumoral activity towards human glioblastoma cell line were also observed, but the aqueous extract showed no cytotoxicity to healthy murine cells. Compounds derived from the aqueous soybean meal extract have the potential to be used as health promoting agents.Entities:
Keywords: antimicrobial and antimitogenic activities; bioaccessibility; extruded-soy material; isoflavones; non-cytotoxic; polyphenols
Mesh:
Substances:
Year: 2018 PMID: 30587803 PMCID: PMC6337456 DOI: 10.3390/molecules24010074
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Bioaccessibility of isoflavones from soybean meal aqueous extract estimated by in vitro simulated gastrointestinal digestion (mg/100 g).
| Gastrointestinal Digestion (mg/100 g of Dry Weight) | Colonic Fermentation (mg/100 g of Dry Weight) | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |||||||
| Acetyldaidzin | 3.0 ± 0.02 c | 3.0 ± 0.02 c | 1.3 ± 0.01 d | 1.2 ± 0.01 d | 1.8 ± 0.02 d | 10.1 ± 0.02 a | 6.8 ± 0.02 b |
| Acetylgenistin | 3.0 ± 0.01 a | 2.0 ± 0.02 b | 2.0 ± 0.01 b | 2.5 ± 0.03 b | 2.7 ± 0.01 a | 3.4 ± 0.01 a | 3.5 ± 0.02 a |
| Acetylglycitin | 0.6 ± 0.01 a | 0.3 ± 0.02 a | 0.3 ± 0.01 a | 0.2 ± 0.03 a | 0.8 ± 0.01 a | nd | nd |
|
|
|
|
|
|
|
|
|
|
| |||||||
| Daidzein | 3.0 ± 0.01 d | 2.0 ± 0.01 e | 1.1 ± 0.01 f | 4.0 ± 0.01 d | 21.1 ± 0.05 a | 12.7 ± 0.04 b | 7.1 ± 0.01 c |
| Genistein | 5.0 ± 0.03 b | 3.0 ± 0.01 c | 2.0 ± 0.02 d | 2.2 ± 0.02 d | 11.8 ± 0.05 a | 5.8 ± 0.02 b | 4.6 ± 0.01 b |
| Glycitein | 0.3 ± 0.01 d | 0.2 ± 0.01 d | 1.0 ± 0.01 e | 1.9 ± 0.01 e | 24.7 ± 0.06 a | 15.7 ± 0.05 b | 7.1 ± 0.01 c |
|
|
|
|
|
|
|
|
|
|
| |||||||
| Daidzin | 35.0 ± 0.02 a | 34.0 ± 0.01 a | 33.0 ± 0.02 a | 10.0 ± 0.01 b | nd | nd | nd |
| Genistin | 49.0 ± 0.02 a | 48.0 ± 0.02 a | 48.5 ± 0.01 a | 11.0 ± 0.01 b | nd | nd | nd |
| Glycitin | 16.0 ± 0.03 a | 15.0 ± 0.01 a | 14.5 ± 0.02 b | 4.0 ± 0.03 c | nd | nd | nd |
|
|
|
|
|
|
|
|
|
|
| |||||||
| Malonyldaidzin | 7.0 ± 0.03 a | 6.0 ± 0.03 a | 3.0 ± 0.001 b | 1.0 ± 0.03 c | nd | nd | nd |
| Malonylgenistin | 13.0 ± 0.01 b | 16.0 ± 0.02 a | 5.0 ± 0.001 c | 2.0 ± 0.04 d | nd | nd | nd |
| Malonylglycitin | 4.0 ± 0.01 a | 3.0 ± 0.03 a | 1.0 ± 0.001 b | 0.3 ± 0.03 c | nd | nd | nd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PD, Pre-digestion; OD, oral digestion; GD, gastric digestion and ID, intestinal digestion. Values are expressed as the mean ± standard deviation (n = 3). a, b, c, d, e Different letters within the same line indicate differences between in vitro digestion and colonic fermentation of a compound at significance level p < 0.05. nd, not detected. Soybean meal aqueous extract was submitted to in vitro gastrointestinal digestion, simulating the oral, gastric and intestinal phases based on human physiology.
Bioaccessibility of phenolics from soybean meal aqueous extract.
| Phenolic Compounds | PD | OD | GD | ID |
|---|---|---|---|---|
| mg/100 g of Dry Weight | ||||
|
| ||||
| Salicylic acid | 3.8 ± 0.01 a | 2.0 ± 0.2 b | 2.0. ± 0.01 b | 2.1 ± 0.2 b |
| Caffeic acid | 6.1 ± 0.1 a | 2.3 ± 0.2 d | 3.0 ± 0.2 c | 3.8 ± 0.3 b |
| Ferulic acid | 0.3 ± 0.02 b | 0.9 ± 0.01 a | 0.9 ± 0.01 a | 1.0 ± 0.02 a |
| Gallic acid | 7.7 ± 0.1 a | 1.1 ± 0.0 d | 2.9 ± 1.3 c | 4.8 ± 0.30 b |
| Syringic acid | 8.1 ± 0.1 a | 1.1 ± 0.01 d | 2.0 ± 0.3 c | 4.3 ± 0.3 b |
| Vanillic acid | 9.1 ± 0.2 a | 1.3 ± 0.02 d | 3.6 ± 0.6 c | 6.2 ± 1.6 b |
| 4-hydroxybenzoic acid | 5.1 ± 0.1 a | 1.2 ± 0.1 c | 3.1 ± 0.9 b | 1.7 ± 0.4 c |
|
|
|
|
|
|
|
| ||||
| 5-caffeoylquinic chlorogenic acid | 3.5 ± 0.2 a | 1.0 ± 0.1 c | 2.4 ± 0.3 b | 1.3 ± 0.1 c |
| 2.0 ± 0.1 a | 1.0 ± 0.01 b | 1.1 ± 0.1 b | 1.2 ± 0.1 b | |
| 4-hydroxyphenylacetic acid | 3.4 ± 0.1 a | 1.0 ± 0.1 c | 1.6 ± 0.1 b | 1.0 ± 0.1 c |
| Sinapic acid | 2.7 ± 0.1 a | 1.0 ± 0.1 b | 1.1 ± 0.1 b | 1.0 ± 0.1 b |
|
|
|
|
|
|
|
| ||||
| Hesperidin | 9.1 ± 0.4 a | 1.2 ± 0.2 d | 7.1 ± 0.6 b | 4.2 ± 0.6 c |
| Kaempferol | 0.4 ± 0.01 a | 0.9 ± 0.1 a | 0.9 ± 0.1 a | 0.9 ± 0.1 a |
| Myricetin | 5.0 ± 0.01 a | 1.3 ± 0.1 c | 1.7 ± 0.1 c | 3.2 ± 0.6 b |
| Naringin | 2.5 ± 0.5 a | 0.9 ± 0.1 c | 1.0 ± 0.1 c | 1.6 ± 0.8 b |
| Rutin | 4.9 ± 0.1 a | 1.8 ± 0.1 c | 2.1 ± 0.9 b | 2.6 ± 0.1 b |
|
|
|
|
|
|
|
|
|
|
|
|
Values are the sum of soluble phenolics plus those extracted by acid or alkali, expressed as the mean ± standard deviation (n = 3). a, b, c, d Different letters within the same line indicate differences between in vitro digestion of a compound at significance level p < 0.001. Soybean meal aqueous extract was submitted to in vitro gastrointestinal digestion, simulating the oral, gastric and intestinal phases based on human physiology. PD, Pre-digestion; OD, oral digestion; GD, gastric digestion; ID, intestinal digestion.
Figure 1Antioxidant activity following in vitro simulated gastrointestinal digestion. Antioxidant capacity (TEAC), ferric reducing ability in plasma (FRAP), total antioxidant potential (TAP) and oxygen radical antioxidant capacity (ORAC) from aqueous soybean meal extract, after in vitro simulated gastrointestinal (oral, gastric and intestinal) digestion. Values are expressed as the mean ± standard deviation (n = 3). Different letters denote difference between means of each antioxidant activity determinations before and after in vitro gastrointestinal digestion (one-way ANOVA, Bonferroni’s post-test), where p < 0.05. FRAP assays did not exhibit differences.
Minimal inhibitory concentration of the aqueous extract from soybean meal.
| Microorganisms | Soybean Meal Aqueous Extract Concentration (mg/mL) | Inhibition (%) |
|---|---|---|
|
| ||
| 150 | 21 ± 2.1 | |
| 75 | 100 ± 0.0 | |
| 120 | 100 ± 0.0 | |
|
| ||
| 12.5 | 100 ± 0.0 | |
| 90 | 100 ± 0.0 | |
| 50 | 100 ± 0.0 | |
| 35 | 100 ± 0.0 | |
| 100 | 100 ± 0.0 | |
| 75 | 100 ± 0.0 | |
| 75 | 100 ± 0.0 | |
| 100 | 100 ± 0.0 | |
| 150 | 100 ± 0.0 |
Growth inhibition was determined using different concentrations of the aqueous extract tested on 106 cells of each strains, 12.5 to 150 mg/mL at 37 °C for 18 h. Next, cells were serially diluted (1/10), plated, incubated at 37 °C for 18 h and colony-forming units were counted. Values expressed as the mean ± standard deviation (n = 3). * Strain isolated from Minas frescal cheese [18]; ** strain isolated from oil refinery sludge [19].
Figure 2Cytotoxicity of soybean meal aqueous extract on mouse bone marrow (BM) cells and fibroblast L929 cell lines and on the human glioblastoma U-87 MG cell line. Growth versus soybean meal aqueous extract concentration plot (left-hand panel) after 24 h exposure. Right-hand panel shows the inhibition versus Log of soybean meal aqueous extract concentration after 24 h exposure. Results were expressed as the mean ± standard deviation (n = 3). Differences between the untreated cells (control) and those incubated with concentrations from 125 mg/mL to 0.97 mg/mL of soybean meal aqueous extract were evaluated by the One-way ANOVA test, with the Tukey post-test where ** p < 0.01; *** p < 0.001; **** p < 0.0001.